GILBERT MEDIDA: Open Payments
NPI 1265517700 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 64 payments from 19 companies in 2025. Trend: 2023 $1,396 · 2024 $1,850 · 2025 $1,990
Food & beverage: $1,990
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $517 |
| AstraZeneca Pharmaceuticals LP | 8 | $363 |
| Phathom Pharmaceuticals, Inc. | 3 | $209 |
| ViiV Healthcare Company | 1 | $121 |
| REVANCE THERAPEUTICS, INC. | 2 | $114 |
| Corcept Therapeutics | 5 | $102 |
| Esperion Therapeutics, Inc. | 5 | $101 |
| ABBVIE INC. | 4 | $96 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 2 | $47 |
Products named: Wegovy, VOQUEZNA, BREZTRI, Ozempic, AIRSUPRA, APRETUDE, DAXXIFY, Korlym.
Industry payments across FL — which companies pay providers there.
